Aspirin chemoprevention in Lynch syndrome should now be a standard of care, say researchers who report that aspirin halved the risk of developing cancer in decade-long trial published onlinetoday in the Lancet.
31.10.11
Aspirin Chemoprevention Now Recommended in Lynch Syndrome
Aspirin Chemoprevention Now Recommended in Lynch Syndrome
Aspirin chemoprevention in Lynch syndrome should now be a standard of care, say researchers who report that aspirin halved the risk of developing cancer in decade-long trial published onlinetoday in the Lancet.
Aspirin chemoprevention in Lynch syndrome should now be a standard of care, say researchers who report that aspirin halved the risk of developing cancer in decade-long trial published onlinetoday in the Lancet.
Přihlásit se k odběru:
Komentáře k příspěvku (Atom)
Žádné komentáře:
Okomentovat
Poznámka: Komentáře mohou přidávat pouze členové tohoto blogu.